John A MacPhee Insider Trading $ADMS Adamas Pharmaceuticals Inc
Get free email notifications about insider trading for John A MacPhee.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John A MacPhee. John A MacPhee is EVP, Pres - Strativa in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres Strativa Pharma in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Strativa in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Strativa Pharma in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres.-Strativa in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, President, Strativa Pharm in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres Branded Prod Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres, Strativa Pharm in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Pres, Branded Products Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Pres. Branded Products Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Director in Adamas Pharmaceuticals Inc ($ADMS).
John A MacPhee in Adamas Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John A MacPhee: Director
Holdings: 197,000 shares
Current Value: $3,183,520
Latest Transaction: Mar 16 2021
$ADMS Market Capitalization: $364.02M
$ADMS Previous Close: $16.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John A MacPhee in Adamas Pharmaceuticals Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | M | 0.67 | 192,000 | 127,680 | 0 | |
| Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Buy | M | 0.67 | 192,000 | 127,680 | 197,000 | 5 K to 197 K (+3,840.00 %) |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 2.70 | 10,000 | 27,000 | 10,000 | |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Jun 06 2019 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 4.80 | 10,000 | 48,000 | 10,000 | |
| Jun 07 2018 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 27.98 | 10,000 | 279,800 | 10,000 | |
| Jun 02 2017 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 16.27 | 15,000 | 244,050 | 15,000 | |
| Aug 08 2016 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 13.68 | 12,600 | 172,368 | 12,600 | |
| Jun 07 2016 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 17.03 | 15,000 | 255,450 | 15,000 | |
| May 18 2015 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 17.97 | 21,000 | 377,370 | 21,000 |
Page: 1